-
Your ultimate guide to Spring TV: 30 treats you won't want to miss - from the return of a dystopian smash hit to a fiendish new game show Traitors fans will love
05 Apr 2025 09:26 GMT
BLOOMING BRILLIANT! 30 TV TREATS YOU WON’T WANT TO … of Rotterdam to ease illegal drug shipments to Ireland.
The … befriended them before lacing their medicationsand rewriting their wills.
NOEL EDMONDS …
It centres on children with haemophilia who were sent to a …
-
FDA awards ODD status to Sanofi’s rilzabrutinib for two rare conditions
04 Apr 2025 08:38 GMT
… Food and Drug Administration (FDA) orphan drug designation (ODD) to treat two rare … Outcomes from a Phase IIb trial in wAIHA patients demonstrated meaningful …
The latest development follows Sanofi’s recent FDA approval for its haemophilia treatment, Qfitlia …
-
Germany will reimburse haemophilia gene therapy Hemgenix
03 Apr 2025 18:43 GMT
… reimbursement coverage of its haemophilia B gene therapy Hemgenix, … a treatment for severe and moderately severe haemophilia B … needed to take FIX drugs for several years.
In … trial – presented at the annual congress of the European Association for Haemophilia …
-
Sanofi’s Qfitlia approved by FDA as first haemophilia therapy for all patients
31 Mar 2025 14:07 GMT
… Food and Drug Administration (FDA) approval for haemophilia treatment Qfitlia (fitusiran … that some haemophilia patients develop that prevent … recent drugs approved by the FDA for haemophilia.
Qfitlia … to GlobalData’s Pharma Intelligence Center. Roche …
-
Sanofi’s Qfitlia granted FDA approval to treat haemophilia A or B
31 Mar 2025 11:36 GMT
… Food and Drug Administration (FDA) as the first therapy to treat haemophilia A or … joints and organs.
Utilising Alnylam Pharmaceuticals’ ESC-GalNAc conjugate technology, Qfitlia … .
“Our robust portfolio of haemophilia treatment options continues to grow as …
-
JW Pharmaceutical's 'Hemlibra' Proven to Improve Quality of Life for Patients with Severe Hemophilia A
31 Mar 2025 07:22 GMT
… the annual European Association for Haemophilia and Allied Disorders (EAHAD … Hemophilia A treated with their drug 'Hemlibra.'
… a change in medication but a treatment option that can … said an official from JW Pharmaceutical. "We hope Hemlibra …
-
Rare diseases: Rising treatment costs a growing concern in Karnataka
29 Mar 2025 09:37 GMT
… patients affected
Diseases such as haemophilia, thalassemia, Pompe disease, Gaucher … with rare diseases require continuous treatment and medication. The Rs 50 lac … difficulties in medication availability for patients. The center also treats children …
-
Hemophilia A Treatment Market Size In 7MM Is Expected To Grow At A Decent CAGR By 2034, Estimates Delveinsight
29 Mar 2025 00:40 GMT
… haemophilia A undergoing major surgery requiring FVIII treatment … gene therapy for treating severe hemophilia A. … alfa): Takeda
OBIZUR treats bleeding episodes in … Drugs
Fitusiran, currently under development by Sanofi (Genzyme)/Alnylam Pharmaceuticals …
-
PGI to start clinical trial of CAR T-cell therapy for cancer treatment
23 Mar 2025 07:09 GMT
… advanced cancer treatment, PGI will soon start clinical trial of … already proven effective in treating leukaemia and lymphoma, is … conditions like thalassemia and haemophilia. "The cost … foster domestic gene therapy development," said Prof Sood …
-
Hemophilia B Pipeline 2024: MOA, ROA, And Clinical Trial Insights Explored By Delveinsight | Novo Nordisk, Sanofi, Pfizer, Belief Biomed, Centessa Pharma
18 Mar 2025 01:52 GMT
… treatments were administered at haemophilia centres in France. HEMGENIX underwent extensive clinical development … Behring, GC Pharma, Kaifeng Pharmaceutical, KM Biologics … B Drugs under development based … websites, clinical trial registries, conferences, …
About
© 1995-2025